VP, Clinical&Translational Sc of Axogen, Inc. (NASDAQ:AXGN), Devinney Erick Wayne, sells 371 shares worth $6,608
According to Axogen, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 05:33 PM, company VP, Clinical&Translational Sc, Devinney Erick Wayne disclosed selling 371 shares at a cost of $17.81. At the time of this transaction (Dec 29), this trade was worth $6,608 in total. As of Dec 29, Devinney Erick Wayne now owns 63,240 shares in total worth about $1,119,348.0.
For the last few recent trades made by Axogen, Inc. (NASDAQ:AXGN) VP, Clinical&Translational Sc, Devinney Erick Wayne, we have the following information:
- SEC Form 4 filing: Dec 21: Sold 147 shares at the rate of $16.42 per share. Total worth of this trade was $2,414. Total number of shares owned as of Dec 21 were 62,111
Posted by
George Daniels
on Wednesday December 30 2020, 8:32 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
